在宁波妇儿医院关于"小洛熙"的医疗纠纷曝光后，有上海相关儿科心脏医生告诉第一财经记者："最近 门诊宁波来的孩子比较多，都跑出来看病了。" 近日，宁波大学附属妇女儿童医院的医疗风波引发业内对先天性心脏病学科发展的关注。 12月22日，第一财经记者从宁波妇儿医院方面了解到，目前该院小儿胸心外科住院及手术医疗服务已暂 停，何时恢复尚不确定。 多名心脏科医生对第一财经记者表示，近年来，儿童先天性心脏病外科的手术量整体有所下降，并且向 头部大中心聚集的趋势加剧，一些地方医院的手术量下降非常显著。 "先心病外科面对的复杂病例数量和疾病谱相比10年前发生了显著变化。"一位上海三甲医院心脏中心主 任对第一财经记者表示。 多位心脏科医生告诉第一财经记者，这几年先心外科手术量"下降得厉害"。一位宁波某医院心脏科医生 告诉第一财经记者："上级医院忙得要命，下级医院空得要命，病人累得要命。" 相关专家告诉第一财经记者，导致这种现状的一个原因是，近年来大中心在全国各地开设了大量的"区 域中心"，例如上海儿童医学中心在全国拥有四个区域中心，也从一定程度上吸引了地方的患者。 根据中国医学科学院阜外医院小儿心脏外科中心主任李守军去年发表的一 ...

闫东杰定期坐诊，让当地群众无需赴京就能获国家级专家精准诊疗，降低就医成本。同时，通过临床带 教、手术指导等，促进医院胸外科团队成长，为"健康菏泽"建设注入动力。 闫东杰拥有超30年一线临床经验，在肺癌、食管癌等胸外科疾病综合治疗方面造诣深厚，尤其擅长各类 胸外科微创手术。坐诊期间，他上午在丹阳路院区会诊患者，下午前往大学路院区主刀完成"左肺上叶 舌段切除术"，兑现"把北京专家请到家门口"的承诺。 为解决菏泽及周边地区胸外科患者"看名医难、赴京就医远"的难题，近日，首都医科大学附属北京胸科 医院微创中心知名主任医师闫东杰再次来到菏泽市中医医院，为鲁西南群众提供与北京同质化的优质胸 外科诊疗服务。 ...

近日，网红医生"烧伤超人阿宝"（本名宁方刚）在自己的微博账号连续发文回应，称艾芬（微博用户名"急诊向日葵艾芬"）自2023年开始举报其的赞赏纳税 问题，事后税务部门找其三次。他表示自己既非偷税也非漏税。 据宁方刚透露，自媒体文章赞赏收入纳税认定此前无明确规定。2024年12月，北京西城税务部门要求其赞赏收入按劳务所得缴税，而且应该支付滞纳金，但 宁表示对计税方式和滞纳金有异议。一年后，2025年10月，西城税务部门再次通知他，明确表示文章就是按照劳务所得缴税，让他赶紧去申报补交。此后， 宁方刚完成足额补缴。 宁方刚还在文章中提到，在这几次沟通过程中，他表示得到朋友的消息称，沈阳税务部门曾认定自媒体文章赞赏属于个人自愿小额赠予，无需缴税。北京西 城税务部门有关领导为此特意向国家税务总局询问，得到的回复是沈阳那边的做法已经被纠正。 此前，12月19日，艾芬通过自己的微博账号晒出国家税务总局北京市西城区税务局税收违法行为查处结果告知书，告知书显示，艾芬举报的宁方刚因微信、 微博发表文章获取赞赏收入涉嫌存在未按规定缴纳个人所得税。经核查，被检举人依法补缴税款及滞纳金合计846367.61元，上述款项已入库。 据奔流新 ...

Core Viewpoint - The global competitiveness of Chinese innovative pharmaceutical companies is continuously improving, with a focus on innovation in treatment areas and technology platforms [1] Group 1: Treatment Areas - The commercial health insurance premium scale has significant growth potential and is expected to become a new source of medical payment [1] - Fast-growing treatment areas include cutting-edge technologies such as GLP-1, ADC, and bispecific antibodies [1] - In addition to existing popular fields like oncology and immunology, potential treatment areas to watch include metabolic diseases (e.g., weight loss), chronic diseases (e.g., hypertension, hyperlipidemia), and central nervous system disorders (e.g., Alzheimer's, Parkinson's) [1] Group 2: Technology Platforms - Potential technology platforms to focus on include small nucleic acid drugs, radioactive drugs (RDC), and CAR-T therapies [1] Group 3: Medical Device Industry - The medical device industry is currently under pressure due to policy impacts, but the fundamentals are expected to improve with the ongoing implementation of anti-involution policies, clearing of centralized procurement, and innovation upgrades by companies along with international business expansion [1] Group 4: Investment Products - The Guotai Innovation Pharmaceutical ETF (159377) tracks the Innovation Pharmaceutical Index (399275), which has a daily price fluctuation limit of 20% [1] - This index focuses on the innovative biopharmaceutical sector, selecting listed company securities involved in biopharmaceuticals, chemical pharmaceuticals, and medical services to reflect the overall performance of pharmaceutical companies with high R&D investment and innovation capabilities, leaning towards high-tech and growth styles [1]

Core Insights - The establishment of the Boao Lecheng International Medical Tourism Pilot Zone marks a significant milestone in China's medical innovation and policy experimentation, particularly in the context of the Hainan Free Trade Port's opening [1][3] Group 1: Policy and Development - The Boao Lecheng Pilot Zone is recognized as China's only "medical special zone," leveraging four key policy advantages: licensed medical practices, research, operations, and international exchanges, which are driving substantial development effects [3] - The zone has facilitated the approval of 21 international advanced medical devices and 16 special medical foods for clinical use, along with the successful implementation of 16 biomedical new technologies [3] - The goal is to synchronize medical technology, equipment, and pharmaceuticals with international standards by 2025, aiming for over 520 international innovative medical devices to undergo clinical applications in China for the first time [3] Group 2: Clinical Innovations and Expert Discussions - The conference emphasized the importance of establishing clinical guidelines and technical standards to support the implementation of new technologies, particularly in regenerative medicine and real-world data research [5] - Experts highlighted the need for the committee to focus on standard-setting, technology assessment, and industry collaboration to facilitate the standardized application of clinical new technologies [5] - The committee aims to leverage its expertise in cutting-edge fields like stem cells and xenotransplantation to contribute to industry standards and policy discussions [5] Group 3: Future Directions and Strategic Initiatives - The committee's future work will focus on three main areas: ensuring compliance with industry regulations, promoting integration of new technologies with clinical practices and policies, and enhancing international collaboration [7] - Specific initiatives include establishing a Clinical New Technology Application Transformation Center and a Digital Medical Trading Center, as well as launching projects to support reproductive health policies [7][9] - The collaboration between the China Hospital Association and the Boao Lecheng Pilot Zone is expected to accelerate the integration of international medical resources into the Chinese market, fostering high-level development in healthcare [9]

12月19日，随着三个质子治疗舱同时运行，华中科技大学同济医学院附属协和医院（以下简称协和医 院）质子医学中心正式启用。 作为当前国内技术最先进、规模最大的质子中心之一，协和质子中心率先实现"三舱同启"，并配备全国 首台ProBeam 360°质子放疗系统。这标志着华中地区肿瘤精准治疗水平迎来质的飞跃。 协和医院院长夏家红介绍，医院专项投入200万元资金，用于支持儿童肿瘤治疗公益项目。该资金将覆 盖100名儿童肿瘤患者，为每位患者减免2万元治疗费，切实减轻患者家庭负担。此举既是响应国家卫生 健康委对公立医院公益性的要求，也是医院助力儿童肿瘤治疗、承担社会责任的具体体现。 协和医院党委书记张玉表示，质子医学中心的启用，是协和医院积极响应国家"十五五"发展规划、实施 健康优先发展战略的最新举措。医院将继续坚持"科技创新"与"人文关怀"双轮驱动，利用百年协和的多 学科综合优势，将设备的技术优势转化为科研与临床特长，为更多肿瘤患者提供国内领先、国际一流的 质子治疗"中国方案"。 （文章来源：科技日报） 为彰显公立医院公益性，当天，协和医院对外宣布，该院同步推出"肿瘤患儿关爱行动"，为经评估适合 质子治疗的前100位儿 ...

Core Viewpoint - The article discusses the tax issues surrounding a well-known doctor, Ning Fanggang, who has been reported for failing to pay taxes on income from social media tips and sales through various platforms, highlighting the complexities of tax compliance in the digital economy [3][6][7]. Group 1: Tax Compliance Issues - Ning Fanggang was found to have unpaid taxes and penalties totaling 846,367.61 yuan due to unreported income from social media tips [3][6]. - The whistleblower, Ai Fen, has indicated plans to continue reporting Ning for potential tax violations related to his sales activities on various platforms [4][7]. - Ning Fanggang's income sources include tips from his social media accounts and sales through his own and others' platforms, with significant amounts reported from individual transactions [6][9]. Group 2: Background and Context - Ning Fanggang is a well-known medical professional with a significant following on social media, while Ai Fen is a hospital emergency department director who has been involved in a public dispute with him [9]. - The tax authority's response has been limited to Ning's personal account, leaving his business-related income unaddressed, which Ai Fen aims to rectify through further reporting [7][9]. - Ning has publicly stated that he believes he has complied with tax regulations and has made payments following the tax authority's guidance, despite ongoing disputes regarding the classification of his income [6][7].

来源：格隆汇APP 格隆汇12月22日｜港股上午盘三大指数集体上涨，恒生科技指数涨势相对较强，午间收涨0.89%，恒生 指数、国企指数分别上涨0.2%及0.27%。大型科技股走势分化，百度、阿里巴巴上涨，小米跌超2%，腾 讯飘绿；金银价格再创新高！黄金白银股集体上涨，国家大基金三期布局IC载板领域，半导体芯片股强 势，龙头中芯国际涨超7%。另外，生物医药股、家电股、煤炭股走势低迷。印象大红袍上市首日午间 收跌25%破发，明基医院暴跌43%同样破发。(格隆汇) | 名称 | 最新价 | 涨跌幅 | | --- | --- | --- | | 恒生指数 | 25742.24 | +0.20% | | 800000 | | | | 国企指数 | 8925.39 | +0.27% | | 800100 | | | | 恒生科技指数 | 5528.05 | +0.89% | | 800700 | | | ...

Core Insights - The article highlights the launch of various credit application scenarios in Xiamen, including "credit medical hospitalization," "commercial insurance compensation," credit parking management, and "Xiamen Housing Supermarket," aimed at enhancing citizens' credit life and improving social efficiency [1][2][4][6][7] Group 1: Credit Medical Hospitalization - The "credit medical hospitalization scenario" expands the existing credit medical model from outpatient services to inpatient care, addressing issues related to multiple procedures and financial pressures for citizens [2][3] - The new system simplifies the hospitalization application and verification process, allowing citizens to use existing outpatient credit qualifications without resubmitting documents, thus saving time and reducing costs [3] - A dedicated credit limit of 20,000 yuan is established to alleviate financial burdens, enabling citizens to offset part of their prepayment for hospitalization directly with their credit limit [3] Group 2: Commercial Insurance Compensation - The "commercial insurance compensation" scenario aims to resolve the issue of upfront medical expenses, reducing the time for claims from 7-15 days to 1-3 days through real-time data sharing and automatic settlement [4][5] - The platform integrates with multiple commercial insurance companies, allowing for seamless connection between medical and insurance data, thus streamlining the claims process [4] Group 3: Credit Parking Management - The newly launched credit parking management platform offers a "pay after leaving" service, enhancing the efficiency of parking and reducing disputes over fees [6] - Over 180 parking lots are now connected to the platform, allowing users with a credit score of 650 or above to benefit from this service [6] Group 4: Xiamen Housing Supermarket - The "Xiamen Housing Supermarket" provides a comprehensive platform for real estate information, allowing users to access data on new properties, including project details and pricing [7] - The platform features innovative functions such as virtual tours and professional insights, enhancing the home-buying experience and promoting transparency in real estate transactions [7]

Core Insights - The "Home Healthcare" platform of Handan Mingren Hospital provided emergency medical assistance to an elderly patient, showcasing the effectiveness and warmth of their service [2][3] Group 1: Emergency Response - The nursing department quickly assessed the situation after receiving a call for help regarding an elderly patient with a urinary catheter issue, confirming stable vital signs [2] - Nurses Guo Weihua and Zhang Lu voluntarily abandoned their rest to respond to the emergency, demonstrating commitment to patient care [2] - Upon arrival, the nurses conducted a thorough examination and successfully reinserted the urinary catheter while minimizing discomfort for the patient [2] Group 2: Service Overview - The "Home Healthcare" service aims to extend quality nursing resources and professional medical services to patients at home, addressing the challenges faced by the elderly, disabled, and bedridden individuals [3] - The service enhances accessibility to medical care through precise demand matching, rapid response, and standardized professional handling, earning trust from patients and their families [3] - Future plans for the "Home Healthcare" service include providing comprehensive medical support, including daily care, specialized treatment, and health guidance for more individuals with mobility challenges [3]